ADAR1 Deficiency in Pancreatic Cancer Cells Potentiates cDC1 Activation and Promotes Sensitization to Immunotherapy.

Li B, Wang X, Xie B, Zhong X, Wei P, Lou X, Zhang T, Dong C

Open source

DOI
10.1158/2326-6066.cir-25-1626
Published
2026 Sep 2
Container
Cancer immunology research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/2326-6066.cir-25-1626,
  title = {ADAR1 Deficiency in Pancreatic Cancer Cells Potentiates cDC1 Activation and Promotes Sensitization to Immunotherapy.},
  author = {Li B and Wang X and Xie B and Zhong X and Wei P and Lou X and Zhang T and Dong C},
  year = {2026},
  journal = {Cancer immunology research},
  doi = {10.1158/2326-6066.cir-25-1626},
  url = {https://doi.org/10.1158/2326-6066.cir-25-1626}
}

RIS

TY  - JOUR
TI  - ADAR1 Deficiency in Pancreatic Cancer Cells Potentiates cDC1 Activation and Promotes Sensitization to Immunotherapy.
AU  - Li B
AU  - Wang X
AU  - Xie B
AU  - Zhong X
AU  - Wei P
AU  - Lou X
AU  - Zhang T
AU  - Dong C
PY  - 2026
JO  - Cancer immunology research
DO  - 10.1158/2326-6066.cir-25-1626
UR  - https://doi.org/10.1158/2326-6066.cir-25-1626
ER  - 

APA

B, L., X, W., B, X., X, Z., P, W., X, L., T, Z., & C, D. (2026). ADAR1 Deficiency in Pancreatic Cancer Cells Potentiates cDC1 Activation and Promotes Sensitization to Immunotherapy.. Cancer immunology research. https://doi.org/10.1158/2326-6066.cir-25-1626

Source records